Essential hypertension and 5' upstream core promoter region of human angiotensinogen gene

Hypertension

Volumn 30, Issue 6, 1997, Pages 1325-1330

  Ishigami, Tomoaki ^a   Umemura, Satoshi ^a   Tamura, Kouichi ^a   Hibi, Kiyoshi ^a   Nyui, Nobuo ^a   Kihara, Minoru ^a   Yabana, Machiko ^a   Watanabe, Yasujiro ^a   Sumida, Yoichi ^a   Nagahara, Toshihiro ^a   Ochiai, Hisao ^a   Ishii, Masao ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Angiotensinogen; Core promoter; Hypertension, essential; Mutation

Indexed keywords

ANGIOTENSINOGEN;

ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0030725820     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.6.1325     Document Type: Article

References (43)

1. Tamura K, Umemura S, Fukamizu A, Ishii M, Murakami K. Recent advances in the study of renin and AGT genes: from molecules to the whole body. Hypertens Res. 1995;18:7-18.
2. Dzau VJ, Re R. Tissue angiotensin system in cardiovascular medicine: a paradigm shift? Circulation. 1994;89:493-498.
3. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brrenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press; 1990:81-90.
4. Jeunemaitre X, Florent S, Kotelevster YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
5. Caufield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJL. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;330:1629-1633.
6. Rotimi C, Puras A, Cooper R, McFarlane-Anderson N, Forrester T, Ounbiyi O, Morrison L, Ward R. Polymorphism of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension. 1996;27:558-563.
7. Caufield M, Lavender P, Newell Price J, Farrall M, Kamdar S, Daniel H, Lawson M, De Freitas P, Fogarty P, Clark AJ. Linkage of the AGT gene to human EH in African Caribbeans. J Clin Invest. 1995;96:687-692.
8. Walker WG, Whelton PK, Saito H, Russel RP, Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension. 1979;1:287-291.
9. Kimura S, Mullins JJ, Bunnemann B, Metzger R, Hilgenfeldt U, Zimmermann F, Lacob H, Fuxe K, Ganten D, Kaling M. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J. 1992;11:821-827.
10. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo MS, Takahashi S, Hatae T, Kajiwara N, Yagami K, Murakami K. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen. J Biol Chem. 1993;268:11617-11621.
11. Yang G, Merrill DC, Thompson MW, Rocillard JE, Sigmund CD. Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem. 1994;269:32497-32502.
12. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, Murakami K. Angiotensinogen-deficient mice with hypotension. J Biol Chem. 1994;269:31334-31337.
13. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffmann TM, Maeda N, Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A. 1995;92:2735-2739.
14. Morishita R, Higaki J, Tomita N, Aoki M, Moriguchi A, Tamura K, Murakami K, Kaneda Y, Ogihara T. Role of transcriptional cis-elements, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation. Hypertension. 1996;27(pt 2):502-507.
15. Yanai K, Nibu Y, Murakami K, Fukamizu A. A cis-acting DNA located between TATA box and transcription initiation site is critical in response to regulatory sequence in human angiotensinogen gene. J Biol Chem. 1996;271:15981-15986.
16. Zhao YY, Zhou J, Kumar A. Molecular mechanism of human essential hypertension: a mutation in the proximal promoter of the angiotensinogen gene from hypertensive patients increases its transcription in human hepatoma cells. Circulation. 1996;94(suppl I): I-693. Abstract.
17. Ishigami T, Umemura S, Iwamoto T, Tamura K, Hibi K, Yamaguchi S, Nyui N, Kimura K, Miyazaki N, Ishii M. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation. 1995;91:951-954.
18. Ishigami T, Iwamoto T, Tamura K, Yamaguchi S, Iwasawa K, Uchino K, Umemura S, Ishii M. Angiotensin I converting enzyme (ACE) gene polymrophism and essential hypertension in Japan: ethnic difference of ACE genotype. Am J Hypertens. 1995;8:95-99.
19. Takahashi D, Tamura K, Ushikubo T, Moriya A, Yokoyama N, Nyui N, Chiba E, Hibi K, Ishigami T, Yabana M, Yomiyama M, Umemura S, Ishii M. Relationship between hepatic angiotensinogen mRNA expression and plasma angiotensinogen in patients with chronic hepatitis. Life Sci. 1997;60:1623-1633.
20. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamura M, Ishigami T, Yabana M, Kihara M, Inoue S, Ishii M. Plasma angiotensinogen concentration in obese patients. Am J Hypertens. 1997;10:629-633.
21. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-711.
22. Lifton RP. Genetic determinants of human hypertension. Proc Natl Acad Sci U S A. 1995;92:8545-8551.
23. Zorad S, Fickova M, Zelezna B, Macho L, Kral JG. The role of angiotensin II and its receptors in regulation of adipose tissue metabolism and cellularity. Gen Physiol Biophys. 1995;14:383-391.
24. Ingelfinger JR, Schunkert H, Ellison KE, Pivor M, Zuo WM, Pratt R, Dzau VJ. Intrarenal angiotensinogen: localization and regulation. Pediatr Nephrol. 1990;4:424-428.
25. Sarzani R, Fallo F, Dessi-Fulgheri P, Pistorello M, Lanari A, Paci VM, Mantero F, Rappelli A. Local renin-angiotensin system in human adrenals and aldosteronomas. Hypertension. 1992;19:702-707.
26. Sernia C. Location and secretion of brain angiotensinogen. Regul Pept. 1995;57:1-18.
27. Tamura K, Umemura S, Nyui N, Yamakawa T, Yamaguchi S, Ishigami T, Tanaka S, Tanimoto K, Takagi N, Sekihara H, Murakami K, Ishii M. Tissue-specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats. Hypertension. 1996;27:1216-1223.
28. Clauser E, Bouhnik J, Coezy E, Corvol P, Menard J. Synthesis and release of immunoreactive angiotensinogen by rat liver slices. Endocrinology. 1983;112:1188-1193.
29. Kimura S, Iwao H, Fukui K, Abe Y, Tanaka S. Effect of thyroid hormone on angiotensinogen and renin mRNA levels in rat. Jpn J Pharmacol. 1990;52:282-285.
30. Hong-Brown LQ, Deschepper CF. Effects of thyroid hormone on angiotensinogen gene expression in rat liver, brain, and cultured cells. Endocrinology. 1992;130:1231-1237.
31. Sernia C, Clements JA, Funder JW. Regulation of liver angiotensinogen mRNA by glucocorticoids and thyroxine. Mol Cell Endocrinol. 1989;61:147-156.
32. Klett C, Hellmann W, Suzuki F, Nakanishi S, Ohokubo H, Ganten D, Hackenthal E. Induction of angiotensinogen mRNA in hepatocytes by angiotensin II and glucocorticoids. Clin Exp Hypertens. 1988;10:1009-1022.
33. Klett C, Hellman W, Muller F, Suzuki F, Nakanishi S, Ohokubo H. Angiotensin II controls angiotensinogen secretion at a pretranslation level. J Hypertens. 1988;6:S442-S445.
34. Carretero O, Gross F. Renin substrate in plasma under various experimental conditions in the rat. Am J Physiol. 1967;312:695-700.
35. Murakami E, Eggena A, Barrett JD, Sambhi MP. Differential effects of steroids and nephrectomy on the release of renin substrate from rat brain and liver slices. J Hypertens. 1984;2:29-33.
36. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 1997;99:1786-1797.
37. Lee MA, Bohm M, Paul M, Ganten D. Tissue renin-angiotensin systems their role in cardiovascular disease. Circulation. 1993; 87(suppl IV):IV-7-IV-13.
38. Fornage M, Turner ST, Sing CF, Boerwinkle E. Variation at the M235T locus of the AGT gene and EH: a population-based case-control study form Rochester. Hum Genet. 1995;96:295-300.
39. Castellano M, Muiesan ML, Beschi M, Rizzoni D, Cinelli A, Salvetti M, Pasini G, Porteri E, Bettoni G, Zulli R, Agabiti-Rosei E. Angiotensin II type 1 receptor A/C 1166 polymorphism: relation with blood pressure and cardiovascular structure. Hypertension. 1966;28:1076-1080.
40. Truett J, Cornfield J, Kannel W. A multivariate analysis of the risk of coronary heart disease in Framingham. J Chron Dis. 1967;20:511-524.
41. Bonna KH, Thelle DS. Association between blood pressure and serum lipids in a population: The Tromso Study. Circulation. 1991; 83:1305-1314.
42. Goodfriend TL, Egan B, Stepniakowski K, Dennis LB. Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans. Hypertension. 1995;25:30-36.
43. Morris AD, Petrie JR, Connell JMC. Insulin and hypertension. J Hypertens. 1994;12:633-642.